Thyroid dysfunction and immune checkpoint inhibitor outcomes.

被引：0
|
作者：
von Itzstein, Mitchell S.
Lu, Rong
Ali, Sadia
Xie, Donglu
Cai, Jennifer
Xie, Yang
Gerber, David E.
机构：
[1] UT Southwestern, Dallas, TX USA
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15103
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dynamics of immune-mediated thyroid dysfunction in patients with advanced renal cell carcinoma receiving checkpoint inhibitor therapy.
    Osorio, Juan Carlos
    Patil, Sujata
    Coskey, Devyn Taylor
    Carlo, Maria Isabel
    Feldman, Darren R.
    Hellmann, Matthew David
    Voss, Martin Henner
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Immune checkpoint inhibitor-associated thyroid dysfunction: a disproportionality analysis using the WHO Adverse Drug Reaction Database, VigiBase
    Bai, Xuefeng
    Chen, Xiaoyu
    Wu, Xiaohong
    Huang, Yinqiong
    Zhuang, Yong
    Lin, Xiahong
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2020, 182 (01) : 1 - 9
  • [33] Does immune checkpoint inhibitor-induced thyroid dysfunction impact on side effect profile? A restrospective cohort study.
    Gleeson, Jack Patrick
    Ellis, Haley
    Prior, Lisa Mary
    Watson, Geoffrey Alan
    Nugent, Killian
    Lim, Marvin Chang Jui
    Harrold, Emily
    O'Leary, Connor Gerard
    Kelly, Deirdre
    Kelly, Catherine Margaret
    McCaffrey, John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Immune Checkpoint Inhibitor-induced Thyroid Disorders: A Single Center Experience
    Patrizio, Armando
    Fallahi, Poupak
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (04) : 295 - 299
  • [35] Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes.
    Sahar, Hadeel Neamat
    Aldrich, Jeffrey
    Peterson, Christine B.
    Brito-Dellan, Norman
    Lu, Maggie
    Shoukier, Mahran
    Dickson, Kodwo
    Koom-Dadzie, Kwame
    Kheder, Ed
    Franco-Vega, Maria
    Mohammed, Alyssa
    Muthu, Mayoora
    Simbaqueba, Cesar
    Sibille, Michelle
    Manzano, Joanna-Grace Mayo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Monitoring of thyroid function tests in patients receiving immune checkpoint inhibitor therapy
    Slattery, Timothy
    Sacks, Lori
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 24 - 24
  • [37] Incident Hypertension and Survival Outcomes After Immune Checkpoint Inhibitor Initiation
    Balinski, Alexander
    Royfman, Rachel
    Patel, Prem
    Khan, Sarah
    Wieschhaus, Keaton
    Kola-Kehinde, Onaopepo
    Ghazi, Sanam
    Ferdousi, Mussammat
    Ruz, Patrick
    Gatti-Mays, Margaret
    Adesanya, T. M. Ayodele
    Addison, Daniel
    CIRCULATION, 2024, 150
  • [38] Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
    Jang, Se Ryeong
    Nikita, Nikita
    Banks, Joshua
    Keith, Scott W.
    Johnson, Jennifer M.
    Wilson, Melissa
    Lu-Yao, Grace
    JAMA NETWORK OPEN, 2021, 4 (12)
  • [39] PRESENTATION AND LONG TERM OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR RELATED MYOCARDITIS
    Wallner, Alex
    Nagaraja, Haikady
    Raman, Subha V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1017 - 1017
  • [40] Immune checkpoint inhibitor toxicity and associated outcomes in a geriatric population.
    Polewski, Peter James
    Hayashi-Tanner, Yacki
    Gaddam, Mamatha
    Fisher, Nancy R.
    Kovacs, Attila J.
    Marinier, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345